Literature DB >> 23829894

Capturing the mammalian Hippo: elucidating its role in cancer.

Miki Nishio1, Kohei Otsubo, Tomohiko Maehama, Koshi Mimori, Akira Suzuki.   

Abstract

The Hippo pathway is an evolutionarily conserved kinase cascade involved in cell growth, apoptosis, development and migration. It is also crucial for stem cell self-renewal and the maintenance of genomic stability. In addition, this pathway has the unique capacities to sense aspects of tissue architecture, such as cell polarity and mechanical tensions imposed by the surrounding microenvironment, and to control organ size and shape. All of these properties are frequently altered in tumor cells. In this review, we summarize how dysregulation of mammalian Hippo signaling is implicated in cancer.
© 2013 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23829894     DOI: 10.1111/cas.12227

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  23 in total

Review 1.  Recent Advances of the Hippo/YAP Signaling Pathway in Brain Development and Glioma.

Authors:  Taohui Ouyang; Wei Meng; Meihua Li; Tao Hong; Na Zhang
Journal:  Cell Mol Neurobiol       Date:  2019-11-25       Impact factor: 5.046

2.  Polyomavirus small T antigen interacts with yes-associated protein to regulate cell survival and differentiation.

Authors:  Justin H Hwang; Arun T Pores Fernando; Nathalie Faure; Shaida Andrabi; Guillaume Adelmant; William C Hahn; Jarrod A Marto; Brian S Schaffhausen; Thomas M Roberts
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

3.  MOB1-YAP1/TAZ-NKX2.1 axis controls bronchioalveolar cell differentiation, adhesion and tumour formation.

Authors:  K Otsubo; H Goto; M Nishio; K Kawamura; S Yanagi; W Nishie; T Sasaki; T Maehama; H Nishina; K Mimori; T Nakano; H Shimizu; T W Mak; K Nakao; Y Nakanishi; A Suzuki
Journal:  Oncogene       Date:  2017-03-27       Impact factor: 9.867

Review 4.  Role of Yes-associated protein 1 in gliomas: pathologic and therapeutic aspects.

Authors:  Yong-Chang Liu; Yan-zhou Wang
Journal:  Tumour Biol       Date:  2015-03-07

Review 5.  Hippo-yap signaling in ocular development and disease.

Authors:  Matthew Lee; Navneet Goraya; Seonhee Kim; Seo-Hee Cho
Journal:  Dev Dyn       Date:  2018-04-23       Impact factor: 3.780

6.  Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice.

Authors:  Miki Nishio; Keishi Sugimachi; Hiroki Goto; Jia Wang; Takumi Morikawa; Yosuke Miyachi; Yusuke Takano; Hiroki Hikasa; Tohru Itoh; Satoshi O Suzuki; Hiroki Kurihara; Shinichi Aishima; Andrew Leask; Takehiko Sasaki; Toru Nakano; Hiroshi Nishina; Yuji Nishikawa; Yoshitaka Sekido; Kazuwa Nakao; Kazuo Shin-Ya; Koshi Mimori; Akira Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-22       Impact factor: 11.205

7.  Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP.

Authors:  Cecile Rouleau; Arun T Pores Fernando; Justin H Hwang; Nathalie Faure; Tao Jiang; Elizabeth A White; Thomas M Roberts; Brian S Schaffhausen
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

8.  HIPPO-Integrin-linked Kinase Cross-Talk Controls Self-Sustaining Proliferation and Survival in Pulmonary Hypertension.

Authors:  Tatiana V Kudryashova; Dmitry A Goncharov; Andressa Pena; Neil Kelly; Rebecca Vanderpool; Jeff Baust; Ahasanul Kobir; William Shufesky; Ana L Mora; Adrian E Morelli; Jing Zhao; Kaori Ihida-Stansbury; Baojun Chang; Horace DeLisser; Rubin M Tuder; Steven M Kawut; Herman H W Silljé; Steven Shapiro; Yutong Zhao; Elena A Goncharova
Journal:  Am J Respir Crit Care Med       Date:  2016-10-01       Impact factor: 21.405

Review 9.  Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.

Authors:  Joseph A Clara; Cecilia Monge; Yingzi Yang; Naoko Takebe
Journal:  Nat Rev Clin Oncol       Date:  2019-12-02       Impact factor: 66.675

10.  Hypoxic conditions differentially regulate TAZ and YAP in cancer cells.

Authors:  Libo Yan; Qingchun Cai; Yan Xu
Journal:  Arch Biochem Biophys       Date:  2014-07-29       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.